Sherman KA - Search Results

1

Oral versus transdermal selegiline: antidepressant-like activity in rats.

Gordon MN, Muller CD, Sherman KA, Morgan DG, Azzaro AJ, Wecker L. Gordon MN, et al. Among authors: sherman ka. Pharmacol Biochem Behav. 1999 Jul;63(3):501-6. doi: 10.1016/s0091-3057(99)00016-7. Pharmacol Biochem Behav. 1999. PMID: 10418793

2

Locomotor activity as a predictor of times and dosages for studies of nicotine's neurochemical actions.

Freeman GB, Sherman KA, Gibson GE. Freeman GB, et al. Among authors: sherman ka. Pharmacol Biochem Behav. 1987 Feb;26(2):305-12. doi: 10.1016/0091-3057(87)90123-7. Pharmacol Biochem Behav. 1987. PMID: 2883664

3

Cyclosporine-A increases spontaneous and dopamine agonist-induced locomotor behavior in normal rats.

Borlongan CV, Freeman TB, Scorcia TA, Sherman KA, Olanow WC, Cahill DW, Sanberg PR. Borlongan CV, et al. Among authors: sherman ka. Cell Transplant. 1995 Jan-Feb;4(1):65-73. doi: 10.1177/096368979500400110. Cell Transplant. 1995. PMID: 7728335

4

Cholinesterase inhibitor therapy for Alzheimer dementia: what do animal models tell us?

Sherman KA, Messamore E. Sherman KA, et al. Prog Clin Biol Res. 1989;317:1209-22. Prog Clin Biol Res. 1989. PMID: 2602408

5

Acetylcholine formation from glucose following acute choline supplementation.

Sherman KA, Gibson GE, Perrino P, Garrett K. Sherman KA, et al. Neurochem Res. 1991 Sep;16(9):1009-15. doi: 10.1007/BF00965844. Neurochem Res. 1991. PMID: 1784327

6

Diminished mitogen-induced calcium uptake by lymphocytes from Alzheimer patients.

Gibson GE, Nielsen P, Sherman KA, Blass JP. Gibson GE, et al. Among authors: sherman ka. Biol Psychiatry. 1987 Sep;22(9):1079-86. doi: 10.1016/0006-3223(87)90050-3. Biol Psychiatry. 1987. PMID: 3651529 Free article.

7

Human red blood cell choline uptake with age and Alzheimer's disease.

Sherman KA, Gibson GE, Blass JP. Sherman KA, et al. Neurobiol Aging. 1986 May-Jun;7(3):205-9. doi: 10.1016/0197-4580(86)90044-8. Neurobiol Aging. 1986. PMID: 3724955

8

Advances in Alzheimer therapy: cholinesterase inhibitors.

Ashford JW, Sherman KA, Kumar V. Ashford JW, et al. Among authors: sherman ka. Neurobiol Aging. 1989 Jan-Feb;10(1):99-105. doi: 10.1016/s0197-4580(89)80017-x. Neurobiol Aging. 1989. PMID: 2755560

9

Cortisol responses to cholinergic drugs in Alzheimer's disease.

Kumar V, Smith RC, Sherman KA, Ashford W, Murphy J, Giacobini E, Colliver J. Kumar V, et al. Among authors: sherman ka. Int J Clin Pharmacol Ther Toxicol. 1988 Oct;26(10):471-6. Int J Clin Pharmacol Ther Toxicol. 1988. PMID: 3069749 Clinical Trial.

10

The effect of the selective reversible acetylcholinesterase inhibitor E2020 on extracellular acetylcholine and biogenic amine levels in rat cortex.

Giacobini E, Zhu X D, Williams E, Sherman KA. Giacobini E, et al. Among authors: sherman ka. Neuropharmacology. 1996 Feb;35(2):205-11. doi: 10.1016/0028-3908(95)00157-3. Neuropharmacology. 1996. PMID: 8734490

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

125 results

Search Page

Filters